Applied Psychophysiology and Biofeedback

, Volume 41, Issue 1, pp 103–110 | Cite as

The Efficacy of Neurofeedback in Patients with Major Depressive Disorder: An Open Labeled Prospective Study

Article

Abstract

The purpose of this study was to evaluate the effect of neurofeedback on depressive symptoms and electrophysiological disturbances in patients with major depressive disorder. We recruited participants suffering from depression to evaluate efficacy of left prefrontal beta with alpha/theta training. An 8-week, prospective, open-label study was undertaken. Twenty participants were recruited. The treatment protocol was twice or three times a week training of beta at F3 with alpha/theta at Pz for 8 weeks. When every visit, patients were received beta training for 30 min, and then alpha/theta training for 30 min. Baseline, 4 and 8 week scores of; the Hamilton rating scale for Depression (HAM-D), the Hamilton rating scale for Anxiety (HAM-A), the Beck Depression Inventory (BDI)-II, the Beck Anxiety Inventory (BAI), Clinical global impression-severity (CGI-S), and pre- and post-treatment resting state EEGs were compared. Interhemispheric alpha power asymmetry (A score) was computed for homologous sites F3–F4. Pre- and post-training clinical assessments revealed significant improvements in HAM–D, HAM-A, BDI, and CGI-S scores. Cumulative response rates by HAM-D were 35.0 and 75.0 % at 4 and 8 weeks, respectively, corresponding cumulative remission rates by HAM-D were 15.0 and 55.0 %, respectively. No significant differences were found between pre- and post-treatment A score. Neurofeedback treatment could improve depressive symptoms significantly. In addition, anxiety symptoms and clinical illness severity decreased significantly after neurofeedback treatment. Despite its several limitations, such as, small sample size and lack of a control group, this study suggested neurofeedback has significant effects in patients with major depressive disorder.

Keywords

Neurofeedback Beta training Depression Asymmetry score 

References

  1. American Psychiatric Association. (2000). Diagnostic criteria from DSM-IV-TR. Washington, D.C.: American Psychiatric Association.Google Scholar
  2. Baehr, E., & Baehr, R. (1997). The use of neurofeedback as adjunctive therapeutic treatment for depression: Three case studies. Biofeedback, 25, 10–11.Google Scholar
  3. Baehr, E., Rosenfeld, J. P., & Baehr, R. (2001). Clinical use of an alpha asymmetry neurofeedback protocol in the treatment of mood disorders: Follow-up study one to five years post therapy. Journal of Neurotherapy, 4(4), 11–18.CrossRefGoogle Scholar
  4. Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2006). The Hamilton depression rating scale: Has the gold standard become a lead weight? The American Journal of Psychiatry, 161, 2163–2177.CrossRefGoogle Scholar
  5. Baxter, L. R. Jr., Schwartz, J. M., Phelps, M. E., Mazziotta, J. C., Guze, B. H., Selin, C. E., et al. (1989). Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry, 46(3), 243–250.Google Scholar
  6. Beck, A. T., & Steer, R. A. (1990). Beck anxiety inventory manual. San Antonio, TX: Psychological Corporation.Google Scholar
  7. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for beck depression inventory-II. San Antonio, TX: Psychological Corporation.Google Scholar
  8. Bench, C. J., Friston, K. J., Brown, R. G., Frackowiak, R. S., & Dolan, R. J. (1993). Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychological Medicine, 23(3), 579–590.CrossRefPubMedGoogle Scholar
  9. Bench, C. J., Friston, K. J., Brown, R. G., Scott, L. C., Frackowiak, R. S., & Dolan, R. J. (1992). The anatomy of melancholia–focal abnormalities of cerebral blood flow in major depression. Psychological Medicine, 22(3), 607–615.CrossRefPubMedGoogle Scholar
  10. Bonnet, M. H., & Arand, D. L. (2001). Impact of activity and arousal upon spectral EEG parameters. Physiology & Behavior, 74(3), 291–298.CrossRefGoogle Scholar
  11. Bouyer, J. J., Montaron, M. F., Vahnée, J. M., Albert, M. P., & Rougeul, A. (1987). Anatomical localization of cortical beta rhythms in cat. Neuroscience, 22(3), 863–869.CrossRefPubMedGoogle Scholar
  12. Brody, A. L., Barsom, M. W., Bota, R. G., & Saxena, S. (2001). Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Seminars in Clinical Neuropsychiatry, 6(2), 102–112.CrossRefPubMedGoogle Scholar
  13. Busner, J., & Targum, S. D. (2007). The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont), 4(7), 28–37.Google Scholar
  14. Busner, J., Targum, S. D., & Miller, D. S. (2009). The clinical global impressions scale: Errors in understanding and use. Comprehensive Psychiatry, 50(3), 257–262. doi:10.1016/j.comppsych.2008.08.005.CrossRefPubMedGoogle Scholar
  15. Cheon, E. J., Koo, B. H., Seo, W. S., Lee, J. Y., Choi, J. H., & Song, S. H. (2015). Effects of neurofeedback on adult patients with psychiatric disorders in a naturalistic setting. Applied Psychophysiology and Biofeedback, 40(1), 17–24. doi:10.1007/s10484-015-9269-x.CrossRefPubMedGoogle Scholar
  16. Choi, S. W., Chi, S. E., Chung, S. Y., Kim, J. W., Ahn, C. Y., & Kim, H. T. (2011). Is alpha wave neurofeedback effective with randomized clinical trials in depression? A pilot study. Neuropsychobiology, 63(1), 43–51. doi:10.1159/000322290.CrossRefPubMedGoogle Scholar
  17. Conca, A., Koppi, S., Konig, P., Swoboda, E., & Krecke, N. (1996). Transcranial magnetic stimulation: A novel antidepressive strategy? Neuropsychobiology, 34(4), 204–207.CrossRefPubMedGoogle Scholar
  18. Davidson, R. J. (1998). Anterior electrophysiological asymmetries, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology, 35(5), 607–614.CrossRefPubMedGoogle Scholar
  19. Davidson, R. J., & Henriques, J. B. (2000). Regional brain function in sadness and depression. In J. Borod (Ed.), The neuropsychology of emotion (pp. 269–297). New York: Oxford University Press.Google Scholar
  20. Dias, A. M., & van Deusen, A. (2011). A new neurofeedback protocol for depression. The Spanish Journal of Psychology, 14(1), 374–384.CrossRefPubMedGoogle Scholar
  21. Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824–827.CrossRefPubMedGoogle Scholar
  22. Drevets, W. C., Videen, T. O., Price, J. L., Preskorn, S. H., Carmichael, S. T., & Raichle, M. E. (1992). A functional anatomical study of unipolar depression. The Journal of Neuroscience, 12, 3628–3641.PubMedGoogle Scholar
  23. Earnest, C. (1999). Single case study of EEG asymmetry biofeedback for depression: An independent replication in an adolescent. Journal of Neurotherapy, 3(2), 28–35.CrossRefGoogle Scholar
  24. Galynker, I. I., Cai, J., Ongseng, F., Finestone, H., Dutta, E., & Serseni, D. (1998). Hypofrontality and negative symptoms in major depressive disorder. The Journal of Nuclear Medicine, 39(4), 608–612.PubMedGoogle Scholar
  25. George, M. S., Wassermann, E. M., Williams, W. A., Callahan, A., Ketter, T. A., Basser, P., et al. (1995). Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. NeuroReport, 6(14), 1853–1856.CrossRefPubMedGoogle Scholar
  26. Gruzelier, J. (2009). A theory of alpha/theta neurofeedback, creative performance enhancement, long distance functional connectivity and psychological integration. Cognitive Processing, 10(Suppl 1), S101–S109. doi:10.1007/s10339-008-0248-5. (Epub 2008 Dec 11).CrossRefPubMedGoogle Scholar
  27. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.CrossRefPubMedGoogle Scholar
  28. Hammond, D. C. (2000). Neurofeedback treatment of depression with the Roshi. Journal of Neurotherapy, 4(2), 45–56.CrossRefGoogle Scholar
  29. Hammond, D. C. (2005). Neurofeedback treatment of depression and anxiety. Journal of Adult Development, 12(2), 131–137.CrossRefGoogle Scholar
  30. Henriques, J. B., & Davidson, R. J. (1990). Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects. Journal of Abnormal Psychology, 99(1), 22–31.CrossRefPubMedGoogle Scholar
  31. Kato, T., Shioiri, T., Murashita, J., Hamakawa, H., Takahashi, Y., Inubushi, T., et al. (1995). Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychological Medicine, 25, 557–566.CrossRefPubMedGoogle Scholar
  32. Kung, S., Alarcon, R. D., Williams, M. D., Poppe, K. A., Jo Moore, M., & Frye, M. A. (2013). Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) depression measures in an integrated mood disorders practice. Journal of Affective Disorder, 145(3), 341–343. doi:10.1016/j.jad.2012.08.017.CrossRefGoogle Scholar
  33. Larsen, S., & Sherlin, L. (2013). Neurofeedback an emerging technology for treating central nervous system dysregulation. Psychiatric Clininics of North America, 36, 163–168.CrossRefGoogle Scholar
  34. Leyfer, O. T., Ruberg, J. L., & Woodruff-Borden, J. (2006). Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. Journal of Anxiety Disorders, 20(4), 444–458.CrossRefPubMedGoogle Scholar
  35. Martinot, J. L., Hardy, P., Feline, A., Huret, J. D., Mazoyer, B., Attar-Levy, D., et al. (1990). Left prefrontal glucose hypometabolism in the depressed state: A confirmation. The American Journal of Psychiatry, 147(10), 1313–1317.CrossRefPubMedGoogle Scholar
  36. Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin, 65, 193–207.CrossRefPubMedGoogle Scholar
  37. Murthy, V. N., & Fetz, E. E. (1992). Coherent 25- to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys. Proceedings of the National Academy of Sciences of the United States of America, 89(12), 5670−5674.Google Scholar
  38. Niv, S. (2013). Clinical efficacy and potential mechanisms of neurofeedback. Personality and Individual Differences, 54(6), 676–686. doi:10.1016/j.paid.2012.11.037.CrossRefGoogle Scholar
  39. Osman, A., Barrios, F. X., Aukes, D., Osman, J. R., & Markway, K. (1993). The Beck Anxiety Inventory: Psychometric properties in a community population. Journal of Psychopathology and Behavioral Assessment, 15, 287–297.CrossRefGoogle Scholar
  40. Osuch, E. A., Ketter, T. A., Kimbrell, T. A., George, M. S., Benson, B. E., Willis, M. W., et al. (2000). Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biological Psychiatry, 48, 1020–1023.CrossRefPubMedGoogle Scholar
  41. Pascual-Leone, A., Peris, M., Tormos, J. M., Pascual, A. P., & Catala, M. D. (1996). Reorganization of human cortical motor output maps following traumatic forearm amputation. NeuroReport, 7(13), 2068–2070.CrossRefPubMedGoogle Scholar
  42. Paus, T., Castro-Alamancos, M. A., & Petrides, M. (2001). Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. European Journal of Neuroscience, 14(8), 1405–1411.CrossRefPubMedGoogle Scholar
  43. Peniston, E. G., & Kulkosky, P. J. (1989). Alpha-theta brainwave training and beta-endorphin levels in alcoholics. Alcoholism Clininical and Experimental Research, 13(2), 271–279.CrossRefGoogle Scholar
  44. Reischies, F. M., Hedde, J. P., & Drochner, R. (1989). Clinical correlates of cerebral blood flow in depression. Psychiatry Research, 29(3), 323–326.CrossRefPubMedGoogle Scholar
  45. Rosenfeld, J. P. (1997). EEG biofeedback of frontal alpha asymmetry in affective disorders. Biofeedback, 25(1), 8–25.Google Scholar
  46. Rosenfeld, J. P. (2000). An EEG biofeedback protocol for affective disorders. Clinical Electroencephalography, 31(1), 7–12.CrossRefPubMedGoogle Scholar
  47. Rosenfeld, J. P., Cha, G., Blair, T., & Gotlib, I. H. (1995). Operant (biofeedback) control of left-right frontal alpha power differences: Potential neurotherapy for affective disorders. Biofeedback Self Regulation, 20(3), 241–258.CrossRefPubMedGoogle Scholar
  48. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., et al. (2003). The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDSSR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54, 573–583.CrossRefPubMedGoogle Scholar
  49. Rush, A. J., Trivedi, M. H., Stewart, J. W., Nierenberg, A. A., Fava, M., Kurian, B. T., & Wisniewski, S. R. (2011). Combining medications to enhance depression outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study. The American Journal of Psychiatry, 168(7), 689–701. doi:10.1176/appi.ajp.2011.10111645.CrossRefPubMedGoogle Scholar
  50. Saxby, E., & Peniston, E. G. (1995). Alpha-theta brainwave neurofeedback training: An effective treatment for male and female alcoholics with depressive symptoms. Journal of Clinical Psychology, 51(5), 685–693.CrossRefPubMedGoogle Scholar
  51. Scott, W. C., Kaiser, D., Othmer, S., & Sideroff, S. I. (2005). Effects of an EEG biofeedback protocol on a mixed substance abusing population. The American Journal of Drug and Alcohol Abuse, 31(3), 455–469.CrossRefPubMedGoogle Scholar
  52. Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., & Frank, D. M. (2001). Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A). Depression and Anxiety, 13(4), 166–178.CrossRefPubMedGoogle Scholar
  53. Tomarken, A. J., Davidson, R. J., Wheeler, R. E., & Kinney, L. (1992). Psychometric properties of resting anterior EEG asymmetry: Temporal stability and internal consistency. Psychophysiology, 29(5), 576–592.CrossRefPubMedGoogle Scholar
  54. United States, Depression Guideline Panel, & United States, Agency for Health Care Policy and Research. (1993). Depression in primary care. Rockville, Md. Washington, D.C: U.S. Dept. of Health and Human Services.Google Scholar
  55. Walker, J. E., & Lawson, R. (2013). FP02 beta training for drug-resistant depression—a new protocol that usually reduces depression and keeps it reduced. Journal of Neurotherapy, 17, 198–200.CrossRefGoogle Scholar
  56. Walker, J. E., Lawson, R., & Kozlowski, G. (2007). Current status of QEEG and neurofeedback in the treatment of clinical depression. In J. R. Evans (Ed.), The handbook of neurofeedback (pp. 341–351). Binghampton, NY: Haworth Medical Press.CrossRefGoogle Scholar
  57. Zimmerman, M., Chelminski, I., & Posternak, M. (2004). A review of studies of the Hamilton depression rating scale in healthy controls: Implications for the definition of remission in treatment studies of depression. The Journal of Nervous and Mental Disease, 192(9), 595–601.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of PsychiatryYeungnam University College of Medicine,Yeungnam University Medical CenterDaeguRepublic of Korea
  2. 2.Department of PsychologyYeungnam University College of Medicine,Yeungnam University Medical CenterDaeguRepublic of Korea

Personalised recommendations